TWO-DIMENSIONAL SMOOTH PURSUIT TESTS FOR EARLY PARKINSON’S DISEASE IDENTIFICATION
Objective: To report qualitative analysis of smooth pursuit (SP) abnormalities found in early Parkinson´s disease (PD) patients using one- and two-dimensional test. Background: The eye…Risk of Long-term Care Admissions Among Medicare Patients Treated with Pimavanserin or Other Atypical Antipsychotics for Parkinson’s Disease Psychosis
Objective: To examine all-cause long-term care (LTC) admission risk among PDP patients treated with atypical antipsychotic (AAP). Background: Risk of LTC-admissions associated with off-label AAPs…Evolution of biochemical and clinical signature of GBA-related Parkinson’s Disease: a 2-year longitudinal study
Objective: To evaluate peripheral biochemical markers as well as clinical features of GBA-related Parkinson’s Disease (GBA-PD) subjects over a 2-year follow-up in comparison with NM-PD…A Narrative Review of Literature on Exercise Therapy and Cognitive Impairment in Individuals with Parkinson’s Disease: The Role of Epigenetics as a Mediator.
Objective: This narrative review explored the potential role of exercise as an epigenetic mediator of cognitive function in people with PD and the possible underlying…Parkinson’s Progression Markers Initiative (PPMI) Online expands biomarker research in Parkinson’s disease (PD)
Objective: To establish a large, longitudinal online cohort linked with a selected, intensively assessed cohort of people with and without PD to characterize development and…Impact of Nonmotor Symptoms on The Quality of Life of Parkinson’s Disease Patients
Objective: This study examined the effect of nonmotor symptoms on the quality of life (QoL) of Parkinson's disease (PD) patients. Background: Parkinson's disease has a…Relative bioavailability of levodopa administered as a subcutaneous infusion with ND0612 versus oral immediate-release levodopa/carbidopa tablets
Objective: To determine the relative bioavailability of levodopa when administered as a subcutaneous (SC) levodopa/carbidopa (LD/CD) infusion with ND0612 versus levodopa derived from oral immediate-release…Genetic contribution to domain specific cognitive decline
Objective: To assess differences in cognitive domains between patients with Parkinson’s disease with the LRRK2 and GBA risk mutations Background: Most patients with PD show…Biochemical markers of glucocerebrosidase (GCase) deficiency in primary macrophages derived from GBA1 mutation carriers with and without Parkinson’s disease
Objective: The aim of the present study was to assess biochemical markers in primary macrophages that could distinguish patient with Parkinson’s disease linked to mutations…Binaural acoustic stimulation reduces tremor severity in patients suffering from Parkinson’s disease
Objective: To assess the effects of BBS on motor symptoms in PD. Background: Acoustic stimulation (AS) can improve motor symptoms in Parkinson’s disease (PD) and…
- « Previous Page
- 1
- …
- 233
- 234
- 235
- 236
- 237
- …
- 338
- Next Page »